Vedolizumab induction therapy for patients with Crohn's disease and prior anti-tumour necrosis factor antagonist failure: a randomised, placebor-controlled, double-blind, multicentre trial - Sands, B; Feagan, B; Rutgeerts, P (J Crohns Colitis, 2013)
et al.